Healthcare Services

Gastrointestinal Pathogen Testing Market Revenue Anticipated To Reach $5.06 Billion By 2030 With 3.5% CAGR

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Gastrointestinal Pathogen Testing Market Increase Between 2026 And 2030?

The size of the gastrointestinal pathogen testing market has shown consistent growth over recent years. It is anticipated to increase from $4.23 billion in 2025 to $4.41 billion in 2026, advancing at a compound annual growth rate (CAGR) of 4.2%. This historical growth can be linked to the significant occurrence of gastrointestinal infections, the integration of culture-based testing, the expansion of hospital laboratories, outbreaks of foodborne illnesses, and established public health surveillance initiatives.

The gastrointestinal pathogen testing market size is anticipated to undergo consistent growth over the next few years. It is projected to expand to $5.06 billion by 2030, showing a compound annual growth rate (CAGR) of 3.5%. The expansion during this forecast period can be primarily linked to the increased prevalence of syndromic testing panels, the wider availability of point-of-care diagnostics, the rising demand for quicker turnaround times, the integration of advanced molecular diagnostics, and a heightened awareness of infectious diseases. Key trends expected in the forecast period encompass a growing utilization of multiplex molecular diagnostic panels, an elevated need for rapid stool testing solutions, the further expansion of point-of-care GI diagnostics, an increasing adoption of PCR-based testing methods, and a sharpened focus on infection surveillance.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp

What Market Drivers Are Helping Shape The Gastrointestinal Pathogen Testing Market Expansion?

The increasing frequency of foodborne illnesses is projected to drive the expansion of the gastrointestinal pathogen testing market in the coming years. These illnesses arise from the consumption of food or drinks tainted with harmful microorganisms, toxins, or chemical agents, encompassing conditions such as listeriosis, viral gastroenteritis, taeniasis, and trichinosis. Several factors contribute to the rise in foodborne incidents, including shifts in food production, distribution, and consumption habits, insufficient food safety protocols, and the effects of climate change on food production. Gastrointestinal testing plays a crucial role by pinpointing the exact pathogens causing these illnesses, enabling healthcare providers to identify symptom origins, prescribe suitable treatments, monitor outbreaks, and implement preventative strategies to curb the spread of foodborne diseases. For example, in September 2025, the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, reported that in 2023, the CDC, collaborating with state and regulatory public health partners, investigated 181 potential multistate outbreaks; of these, 84 were confirmed outbreaks. Outbreak investigators successfully resolved 50 outbreaks (60%), with a suspected source identified for 22 outbreaks and a confirmed source for 28 outbreaks. Consequently, the growing occurrence of foodborne diseases is a key factor boosting the gastrointestinal pathogen testing market.

How Is Segment Classification Applied In The Gastrointestinal Pathogen Testing Market?

The gastrointestinal pathogen testing market covered in this report is segmented –

1) By Pathogen Type: Bacteria, Viruses, Parasites

2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types

3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types

4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users

Subsegments:

1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens

2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens

3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens

What Trends Are Influencing The Future Of The Gastrointestinal Pathogen Testing Market?

Companies operating within the gastrointestinal pathogen testing market are increasingly focused on developing advanced solutions, such as metagenomic diagnostic tests, to improve the accuracy, speed, and overall comprehensiveness of detecting gastrointestinal pathogens. A metagenomic diagnostic test is a sophisticated technology employed to analyze the genetic material of microorganisms present in a sample, such as stool or blood. For example, in April 2024, Microba Life Sciences, an Australia-based biotechnology company, introduced MetaPanel, a metagenomic diagnostic test created to pinpoint a wide array of gastrointestinal pathogens with exceptional accuracy. MetaPanel covers 175 pathogen targets in a single test, providing healthcare professionals with an extensive solution for diagnosing both common and difficult-to-detect infections. It utilizes next-generation sequencing (NGS) technology to analyze a broad spectrum of genetic material in a stool sample. This capability allows for the identification of numerous potential pathogens, including those not routinely screened for in traditional GI panels.

Which Companies Form The Competitive Landscape Of The Gastrointestinal Pathogen Testing Market?

Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics

Access The Complete Gastrointestinal Pathogen Testing Market Report:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

Which Area Represents The Largest Portion Of The Gastrointestinal Pathogen Testing Market?

North America was the largest region in the gastrointestinal pathogen testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Gastrointestinal Pathogen Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=15571&type=smp

Browse Through More Reports Similar to the Global Gastrointestinal Pathogen Testing Market 2026, By The Business Research Company

Capsule Endoscopy System Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/capsule-endoscopy-system-global-market-report

Endoscopic Ultrasound Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/endoscopic-ultrasound-global-market-report

Endoscopy Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/endoscopy-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795